With global diabetes cases projected to reach 1.3 billion by 2050, the market for diagnostic tools that track blood sugar control is suddenly in the spotlight. A new report from The Business Research Company reveals that the boronate affinity tests industry is poised for double-digit growth over the next several years.
The Business Research Company’s Boronate Affinity Tests Global Market Report 2026 – Market Size, Trends, And Forecast 2026-2035
The boronate affinity tests market has already seen notable expansion, propelled by improvements in healthcare diagnostics and research. As the appetite for precision testing and cutting-edge technologies grows, this sector is forecast to keep climbing steadily. Here’s a closer look at the current valuation, the forces driving change, the dominant regions, and the trends likely to define the road ahead.
Also worth a look: Eltropy CEO Ashish Garg wins executive leadership award as AI powers 750 credit unions and HandicapMD publishes guide to untangle Mississippi’s Form 76-104 parking placard process.
Steady Growth Predicted for the Boronate Affinity Tests Market Size
The boronate affinity tests market has experienced robust growth in recent years. According to the report, the market is expected to climb from $3.81 billion in 2025 to $4.19 billion in 2026—a compound annual growth rate (CAGR) of 9.9%. This past expansion can be traced to several factors: a rising incidence of diabetes diagnostics, expanding proteomics research, increased investment in pharmaceutical research and development, wider adoption of affinity chromatography techniques, and a growing reliance on biomarker-based testing methods.
Download a free sample of the boronate affinity tests market report:
https://thebusinessresearchcompany.com/sample_request?id=88216094&type=smp&name=Boronate%20Affinity%20Tests%20Market%20Report%202026&utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Nov_PR
Looking further ahead, the market is expected to sustain its momentum, reaching $6.08 billion by 2030 with a slightly adjusted CAGR of 9.8%. Analysts attribute this projected growth to the rising demand for precision diagnostics, the increasing automation of laboratory workflows, a stronger emphasis on early disease detection, the expansion of personalized medicine research, and the deeper integration of advanced analytical technologies. Key trends during this period are expected to include greater use of boronate-based glycoprotein analysis, a growing need for highly specific affinity assays, widespread deployment of automated boronate affinity instruments, expanded applications in drug discovery, and a sharper focus on high-throughput testing processes.
Understanding Boronate Affinity Tests and Their Applications
Boronate affinity tests work by analyzing interactions between boron-containing compounds and molecules that carry diol or cis-diol functional groups. This distinctive property allows boronate esters to form reversible covalent bonds with diol groups, making them valuable for studying proteins and carbohydrates, as well as for advancing drug development. These tests have become essential instruments across a wide range of biochemical and pharmaceutical research.
View the full boronate affinity tests market report:
https://thebusinessresearchcompany.com/report/boronate-affinity-tests-global-market-report?utm_source=EINPresswire&utm_medium=Paid&utm_campaign=Nov_PR
How the Rising Diabetes Epidemic Fuels Market Demand
The growing number of people living with diabetes is a major catalyst for the boronate affinity tests market. Diabetes—a chronic condition characterized by elevated blood glucose levels due to insufficient insulin production or use—is becoming more prevalent worldwide. Poor dietary habits, including high consumption of processed foods and sugary drinks, along with sedentary lifestyles, are significant contributors. Aging populations and genetic predisposition from family history also elevate the risk. Boronate affinity tests play a crucial role in diabetes management by accurately measuring glycated proteins, providing reliable indicators of long-term blood sugar control. For context, data released in June 2023 by The Lancet projects that global diabetes cases will reach 1.3 billion by 2050, highlighting the urgent need for these diagnostic tools.
Increasing Importance of Personalized Medicine in Market Growth
Another powerful growth driver is the rising emphasis on personalized medicine. This healthcare approach tailors treatment to an individual’s genetic profile, environment, and lifestyle, aiming to improve outcomes. Advances in understanding genetic variation, combined with innovations in diagnostics, bioinformatics, and precision medicine technologies, are accelerating this shift. In the realm of personalized medicine, boronate affinity tests enable precise monitoring of glycation levels, supporting customized management of diabetes and other conditions. For instance, the Personalized Medicine Coalition reported in February 2024 that the FDA approved 16 new personalized therapies for rare diseases in 2023—a significant jump from six approvals in 2022. These included seven cancer-specific drugs and three targeting other diseases, demonstrating how personalized treatment drives demand for advanced diagnostic testing.
Regional Overview Highlighting Market Leaders and Growth Areas
In 2025, North America held the largest share of the boronate affinity tests market. However, the Asia-Pacific region is expected to see the fastest growth during the forecast period. The market analysis covers key territories including Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, offering a comprehensive view of global market dynamics moving forward.
New strategic additions in the 2026 market reports include market attractiveness scoring and analysis, total addressable market (TAM) analysis, company scoring matrix graphics and tables, Excel-based forecasting dashboards, market hotspots infographics, key technologies and future trend analysis, along with updated graphics and tables.
Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email: marketing@tbrc.info
The Business Research Company – www.thebusinessresearchcompany.com
Follow Us On:
• LinkedIn: https://in.linkedin.com/company/the-business-research-company
Oliver Guirdham
The Business Research Company
+44 7882 955267
info@tbrc.info
Visit us on social media:
LinkedIn
Facebook
X
Why it matters: As the global diabetes epidemic accelerates and personalized medicine becomes the new standard of care, the boronate affinity tests market is not just growing—it is becoming a critical pillar of modern diagnostics. For healthcare providers, researchers, and investors, understanding this trajectory is key to anticipating the tools and technologies that will shape patient outcomes for decades to come.
